A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Clinical trial NCT07288567 · RECRUITING
Trial details
- NCT number
- NCT07288567
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-29
- Primary completion
- 2029-12-18
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.